Skip to main content
PR Peptide Repo
  • Home
  • Tools
    • Calculator
    • Protocol Builder
    • Tracker
  • My Data
    • Peptides
    • Subject Log
  • Resources
    • Documentation
    • Science Feed
Sign In EN

Searching our database...

⏳

This peptide is currently being added to our database. Please check back again later.

Peptide not found.

PT-141 (Bremelanotide)

An FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder (HSDD) in premenopausal women.
Learn More
← Previous 1 2 3

About

Verdict-driven peptide guides for clinicians and informed readers. Clear about the evidence — including when there isn't any.

Get our weekly digest →

Quick Links

  • Home
  • Peptides Database
  • Documentation
  • Science Feed

Tools

  • Calculator
  • Protocol Builder
  • Tracker

Connect

  • GitHub

Our Method

  • How We Review Peptides
  • Our Methodology
  • Editorial Standards

Copyright © 2026 Peptide Repo. All rights reserved.

Peptide Repo earns a commission on some links. How we work →

All data is provided for informational and educational purposes only. This platform does not provide medical advice, diagnoses, or treatment recommendations. Always consult qualified professionals.

Translations coming soon.

Support

Contact Engineering

Submit Compound Data

Have data on a peptide not in our directory? Submit it for review.

Submit Compound

Support Policy

Peptide Repo is a research reference database only. All data is provided for informational and educational purposes. This platform does not provide medical advice, diagnoses, or treatment recommendations. Always consult qualified professionals for clinical decisions.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.